Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial

Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata. The core study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-05-14T23:03:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision stamp Revision: v3.5.3 has been added, replacing the previous Revision: v3.5.2. This reflects a software release update shown on the page's footer.
    Difference
    0.1%
    Check dated 2026-04-30T18:07:16.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2, indicating a software version update. This change does not alter study information or page content.
    Difference
    0.1%
    Check dated 2026-04-16T11:04:12.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T20:29:08.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:55:00.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2. The prior Revision: v3.4.1 notice and the government funding lapse notice have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T06:20:29.000Z thumbnail image

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.